It is estimated that by 2020, the global middle class will reach 3.2 billion and swell to 4.9 billion in 2030, by which time Asia will represent a 66% of the global middle-class population1.
The growth in urbanisation and middle class affluence has been characterised by the adoption of sedentary lifestyles which, in turn, has created an epidemic of chronic diseases including cardiovascular, cerebrovascular, diabetes and cancer-related illnesses. Across Asia medical inflation has been running at 7% the last 2 years and is expected to exceed 9% this year2. You can’t afford to ignore it.
 2019 Global Medical Trends Survey Report by Willis Towers Watson
Rising Medical Inflation in Asia Pacific
Contact us to find out how we can help you get covered against potential risk.
Global Client Executive
O: +61 3 96237204